3 Top Growth Stocks to Buy in the Second Half of 2025
Alibaba is a Chinese AI stock that's dirt cheap.
Meta Platforms is making a huge bet on AI that should pay off handsomely.
Vertex Pharmaceuticals is expanding into new indications.
10 stocks we like better than Vertex Pharmaceuticals ›
For decades, Jim McKay introduced ABC's Wide World of Sports with a memorable phrase, "The thrill of victory, and the agony of defeat." McKay's words could apply to many investors in the first half of this year. There have been periods of victory -- and periods of defeat.
Of course, the level of victory and defeat investors experienced depended on which stocks they owned. If you want greater chances of winning going forward, the stocks you pick will make a huge difference. Which stocks should you consider? Here are three top growth stocks to buy in the second half of 2025.
1. Alibaba Group Holding
Wall Street loves Alibaba Group Holding (NYSE: BABA). Of the 40 analysts surveyed by LSEG in July, 37 rated the stock as a "buy" or a "strong buy." The three outliers recommended holding Alibaba. The consensus 12-month price target reflects an upside potential of roughly 40%. I'm not always on the same page as Wall Street analysts, but I agree with the upbeat views about Alibaba.
For one thing, you can't even spell Alibaba without A and I. "Lbaba" just doesn't have the same ring to it. Alibaba is an artificial intelligence (AI) juggernaut in China. Its Alibaba Cloud unit commands 36% of the Chinese cloud infrastructure market, almost twice the market share of its nearest rival. Revenue from Alibaba Cloud's AI-related products has grown by triple-digit percentages for seven consecutive quarters.
The company also operates China's leading e-commerce platform. Alibaba's Taobao and Tmall online shopping sites continue to deliver solid revenue growth, and AI is helping improve the user experience on the platforms.
But the main reason I like Alibaba is its valuation. The stock trades at a forward earnings multiple of only 10.3. That's dirt cheap for a tech giant that raked in $137.3 billion in revenue and $17.4 billion in profits in its last fiscal year.
2. Meta Platforms
Meta Platforms (NASDAQ: META) could be an underappreciated leader in AI. It's not a pure-play AI company like OpenAI. It's not a cloud titan like Amazon (NASDAQ: AMZN), Microsoft (NASDAQ: MSFT), and Alphabet 's (NASDAQ: GOOG)(NASDAQ: GOOGL) Google. However, Meta is making a huge bet on AI that I suspect will pay off handsomely.
That wager is already paying off in some ways. For example, AI is helping Meta improve its recommendation models. The company has seen a 5% higher conversion rate on Reels in the latest quarter. Over the last six months, Meta's recommendation system improvements have led to a 7% increase in user time spent on Facebook and 6% on Instagram. More time on these social media apps translates to higher advertising revenue for Meta.
AI-powered business messaging presents a tremendous growth opportunity for the company. Businesses in developing nations such as Thailand and Vietnam use Meta's messaging apps heavily to communicate with customers. With AI, this model could be deployed in the U.S. and other major markets.
Perhaps the most intriguing arena for Meta, though, is in AI devices. The company is already a leader in smart glasses thanks to its Ray-Ban Meta AI glasses. Its Quest virtual reality headsets remain highly popular with users. I think Meta could be one of the biggest players in a potentially massive AI device market over the next few years.
3. Vertex Pharmaceuticals
Not every great growth stock that I recommend buying in the second half of 2025 is focused heavily on AI. Vertex Pharmaceuticals (NASDAQ: VRTX) is a drugmaker with terrific growth prospects.
So far in Vertex's history, cystic fibrosis (CF) has been the company's primary focus. That's worked out quite well for the big biotech innovator. Vertex markets the only therapies that treat the underlying cause of CF. Its latest CF drug, Alyftrek, offers the most convenient dosing in its lineup and will almost certainly become a blockbuster quickly.
However, Vertex has expanded its horizons to other therapeutic areas. Casgevy, the first approved CRISPR gene-editing therapy, targets two rare blood disorders -- sickle cell disease and transfusion-dependent beta-thalassemia. Earlier this year, Journavx became the first new class of pain medication approved by the U.S. Food and Drug Administration in more than two decades. As a powerful pain drug that isn't an opioid, I expect this new product will become another huge winner for Vertex.
And there are potentially more big winners on the way. Vertex's pipeline features three other drugs in late-stage clinical testing. Inaxaplin targets APOL1-mediated kidney disease. Povetacicept's first targeted indication is chronic kidney disease IgA nephropathy. Zimislicel holds the potential to cure severe type 1 diabetes. I like the chances of success for all three programs.
Should you invest $1,000 in Vertex Pharmaceuticals right now?
Before you buy stock in Vertex Pharmaceuticals, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Vertex Pharmaceuticals wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $687,149!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,060,406!*
Now, it's worth noting Stock Advisor's total average return is 1,069% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of July 15, 2025
John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. Keith Speights has positions in Alphabet, Amazon, Meta Platforms, Microsoft, and Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Alphabet, Amazon, Meta Platforms, Microsoft, and Vertex Pharmaceuticals. The Motley Fool recommends Alibaba Group and recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
39 minutes ago
- Globe and Mail
The Smartest Ethereum ETF to Buy With $500 Right Now
Key Points The iShares Ethereum Trust (ETHA) has attracted more assets than any other Ethereum ETF, with 42% of asset inflows in just the past month. BlackRock's backing provides institutional credibility and virtually unlimited financial resources behind the fund. Buying Ethereum through an ETF eliminates the need for crypto wallets, special exchanges, and fractional coin calculations. 10 stocks we like better than iShares Ethereum Trust - iShares Ethereum Trust ETF › Exchange-traded funds (ETFs) based on the real-time price of Ethereum (CRYPTO: ETH) have been around for a year now. Since the funds were approved and launched in July 2024, Ethereum has gained 7% while the S&P 500 (SNPINDEX: ^GSPC) rose 18%. The leading ETFs have done a great job of tracking this performance precisely, even if the cryptocurrency has been lagging behind stocks recently. But one ETF stands apart from the rest in many ways. If you're planning to enter the Ethereum market via an ETF, the iShares Ethereum Trust (NASDAQ: ETHA) should be at the top of your list. Apart from having the most assets under management (AUM) in its category, the iShares ETF also comes with low fees and a proven fund family. So if you have $500 to spend on a crypto investment today, here's why you should consider the iShares Ethereum Trust. Is Ethereum a good investment? Ethereum is often more volatile than the larger Bitcoin (CRYPTO: BTC) cryptocurrency. For instance, the two crypto giants have both posted approximately 1,200% gains in the last five years, but Ethereum's path to this peak had many more peaks and valleys along the way. The S&P 500 is basically flatlining next to both, even in the midst of the generative artificial intelligence boom: Ethereum Price data by YCharts Now, Ethereum serves a very different purpose than Bitcoin. Instead of a fundamental wealth-holding tool, Ethereum's smart contracts help app developers manage financial tools and trends in a global blockchain ledger. So Ethereum's value doesn't spring from a scarce supply, but from real-world usage of the resulting programs. That makes Ethereum a promising investment if you feel like the financial world could use a whole new set of basic tools. Ethereum-based apps can track ownership of physical assets, execute financial transactions automatically, or manage your digital wallet securely. The Ethereum ledger is readable anytime, from anywhere. At the same time, its encryption effectively makes all of this transaction data immune to hacking and fraud attacks. On this platform, developers can build a wide variety of financial apps, mobile games, and so on. So if you see a market for this sort of thing in the long run, Ethereum has led the blockchain-based app development space for years. It's the industry standard -- for good reason. And that should make Ethereum a solid investment over the years, as decentralized app development continues to gain traction. Why buy via an Ethereum ETF? Buying Ethereum directly often means setting up a new account with a different type of brokerage -- one that can handle cryptocurrency trades rather than stock transactions. You also need to get comfortable with a different type of transaction, where you're usually trading fractions of a digital coin rather than batches of full shares of a stock. Prices are always changing, and you have to figure out where to store your new Ethereum coins. ETFs make the whole process much easier, assuming you already have a stock-trading brokerage account. These funds act just like stocks, with shares usually priced in a comfortable range. A few iShares Ethereum Trust shares at $27 apiece can be more comfortable than a single Ethereum coin at $3,640. What makes the iShares ETF special? As mentioned, the iShares fund is more popular and therefore more liquid than other Ethereum-based ETFs. This makes trading safer and easier, with more stable share prices and quicker transactions. It's part of the world-famous iShares fund family, next to the even more popular iShares Bitcoin ETF (NASDAQ: IBIT) and the massive iShares Core S&P 500 ETF (NYSEMKT: IVV). Financial services giant BlackRock runs the show, giving investors the peace of mind that comes with essentially bottomless financial backing. And like most of its iShares cousins, this one comes with a low fee ratio. At 0.25% per year, it's not exactly the cheapest Ethereum ETF to own, but it comes close to the lowest-cost Grayscale Ethereum Mini Trust (NYSEMKT: ETH) at 0.15%. The BlackRock backing and world-class liquidity can make up for this small gap, and some Ethereum ETFs come with fee ratios as high as 2.5%. The iShares Ethereum Trust is only pulling away from the competition, too. With 42% of AUM inflows over the last month, this fund added more AUM than any other Ethereum ETF has done year to date. You should consider the iShares Ethereum Trust before any other fund in this category. It's a great place to put your next $500 (about 18 shares) of investable cash to work. Market makers broadly agree, judging by the dominant inflows of more funding. Should you invest $1,000 in iShares Ethereum Trust - iShares Ethereum Trust ETF right now? Before you buy stock in iShares Ethereum Trust - iShares Ethereum Trust ETF, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and iShares Ethereum Trust - iShares Ethereum Trust ETF wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $636,628!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,063,471!* Now, it's worth noting Stock Advisor's total average return is 1,041% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 21, 2025 Anders Bylund has positions in Bitcoin, Ethereum, iShares Bitcoin Trust, and iShares Ethereum Trust - iShares Ethereum Trust ETF. The Motley Fool has positions in and recommends Bitcoin and Ethereum. The Motley Fool has a disclosure policy.
Globe and Mail
an hour ago
- Globe and Mail
Is Rivian Stock a Buy Now?
Key Points Rivian manages its key components in-house, including a proprietary technology platform for vehicle controls and autonomous driving features. It leveraged its technology to form a joint venture with Volkswagen, accelerating the development of next-generation electric vehicles. Rivian is scheduled to begin construction of a new EV manufacturing facility in Georgia in 2026. 10 stocks we like better than Rivian Automotive › Rivian Automotive (NASDAQ: RIVN) has captured some investor attention in its quest to establish its place in the electric vehicle (EV) market. Following a meteoric rise after its initial public offering in late 2021, Rivian's stock plummeted in the two years that followed. The stock is still down 92% from its peak. However, recent developments, including its announcement of a joint venture with Volkswagen (OTC: VWAP.Y) and consecutive quarters of positive gross profits, show that Rivian may be turning a corner. Still, challenges remain as the company prepares to expand its manufacturing capacity and scale up production over the next several years. If you're thinking of investing in Rivian, here's what you need to know. Rivian's in-house focus and technology platform Rivian manages nearly all aspects of its business, from engineering to manufacturing, in-house. The company has developed a technology platform that encompasses a comprehensive software stack, covering everything from vehicle controls to the user interface, and enabling over-the-air updates and feature enhancements. Additionally, it features an in-house built autonomy platform with driver-assist technology that can be utilized for autonomous driving. The company leveraged this technology to establish a joint venture with the Volkswagen Group that focuses on software, electronic control units (ECUs), and related network architecture design and development. Volkswagen plans to utilize Rivian's zonal ECU architecture and software stack across its multiple brands. In November, Rivian received $1.3 billion for intellectual property licensed to Volkswagen. Volkswagen has also committed to making additional equity investments of up to approximately $2.5 billion in multiple tranches. Amazon is a major customer and investor One key aspect of Rivian's business since 2019 has been its partnership with Amazon (NASDAQ: AMZN) to develop the Rivian Commercial Van and Electric Delivery Van variants. Today, there are more than 20,000 of these vehicles on the road. In November 2023, their agreement was amended to adjust specific exclusivity rights for Amazon, allowing Rivian to sell its commercial vans to other customers. The Amazon contract has been a major portion of Rivian's business. In 2024, Rivian generated over $1.04 billion in revenue from Amazon -- 21% of its total revenue. In 2025's first quarter, revenue from Amazon totaled $99 million, a significant decrease from the $338 million reported in the same quarter last year. Amazon also holds a significant stake in Rivian, representing 13.3% of its voting power. This partnership with one of the world's largest retailers has been instrumental in helping Rivian establish its foothold in the competitive automotive industry. Still, it will be crucial for the EV maker to develop its other partnerships and revenue streams. What's next for Rivian? Rivian has a history of incurring significant net losses, including a net loss of $4.8 billion last year and a $541 million loss in 2025's first quarter. However, the company did achieve a gross profit of $206 million in Q1, its highest gross profit to date. It was also the company's second consecutive quarter of gross profitability. Management expects to achieve a positive gross profit for 2025 as it continues to focus on cost efficiencies. RIVN Revenue (Quarterly) data by YCharts. The EV maker will continue to ramp up production and add to its facilities. It plans to build a second manufacturing facility near Social Circle, Georgia, to meet demand from the United States and international markets. The plant is expected to have an annual capacity of 400,000 vehicles. It will be built in two phases, each contributing 200,000 units of annual capacity. Construction of that Georgia facility is expected to begin in 2026, with production on the first manufacturing line projected to start in 2028. Vehicles produced there will be on the company's midsize platform, which includes its R2 and R3 models. Development of this facility is supported by a loan arrangement with the U.S. Department of Energy for up to approximately $6.6 billion. Is Rivian right for you? Rivian is expanding its manufacturing footprint, strategically developing its software and services ecosystem, and forming strategic partnerships with key customers and partners. The company is making solid progress in revenue and gross profit, and I would like to see it continue to improve its cost efficiency and profitability. Investors buying today could be getting on the ground floor. That said, analysts project that the EV maker will continue to lose money through 2028, as it will take time and capital to build out its facilities and scale up production. For these reasons, Rivian is a high-risk, high-potential-reward stock that may take years to pay off, making it best suited for aggressive investors with long-term buy-and-hold timelines. Should you invest $1,000 in Rivian Automotive right now? Before you buy stock in Rivian Automotive, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Rivian Automotive wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $636,628!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,063,471!* Now, it's worth noting Stock Advisor's total average return is 1,041% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 21, 2025
Globe and Mail
an hour ago
- Globe and Mail
Prediction: Nvidia Will Soar Over the Next 5 Years. Here's 1 Reason Why.
Key Points Nvidia has the most powerful computer chips, and the major AI developers rely on them to drive their businesses. The total AI opportunity is expected to increase at a high rate over the next five years. 10 stocks we like better than Nvidia › Nvidia (NASDAQ: NVDA) has been that rare stock that has catapulted investors to millionaire status on its own. But up more than 1,500% over the past five years, and with a $4 trillion market cap, can it really still offer growth for investors? It can. Here's why. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » The age of AI All signs are that artificial intelligence (AI) will continue to drive innovation over the next few years as more businesses see how it can help them succeed and grow. As there's greater development in AI, it becomes cheaper and more abundant, and companies that aren't using it to become more efficient and user-friendly are losing out. Nvidia is the leader in the graphics processing units (GPU) that power these trends, with an overwhelming amount of market share. The AI market is growing at a fast pace, and the major players, like Amazon and Microsoft, need Nvidia's powerful chips to drive their efforts. Even companies like Amazon that are creating their own chips to offer more budget-conscious options still partner with Nvidia for their larger clients' needs. According to Statista, the AI market is expected to increase at a compound annual growth rate (CAGR) of 26.6% over the next five years. That's slower than Nvidia's current revenue growth. If you can imagine Nvidia keeping up such a CAGR for its own sales, keeping its price-to-sales ratio constant, that would lead to its stock price nearly tripling. Even if the price-to-sales ratio decreases, there could be some serious gains ahead for Nvidia investors over the next five years and beyond. Should you invest $1,000 in Nvidia right now? Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $636,628!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,063,471!* Now, it's worth noting Stock Advisor's total average return is 1,041% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 21, 2025
